Table 4.
Group | TEAC (mM)* | TBARS (μM) | Thiols (mM) | GSH (μM) | Vit-C (mg/dL) | |
---|---|---|---|---|---|---|
Baseline | Exp | 0.45 ± 0.04f | 4.95 ± 0.52a | 0.23 ± 0.05a | 5.89 ± 0.82e | 2.48 ± 0.17a |
Placebo | 0.48 ± 0.08a | 4.82 ± 0.39a | 0.27 ± 0.04a | 6.16 ± 0.76a | 2.42 ± 0.26a | |
2nd week | Exp | 0.52 ± 0.02e | 4.55 ± 0.41b | 0.23 ± 0.04a | 6.92 ± 0.58d | 2.48 ± 0.14a |
Placebo | 0.47 ± 0.08a | 4.83 ± 0.37a | 0.26 ± 0.04a | 6.34 ± 0.69a | 2.42 ± 0.28a | |
4th week | Exp | 0.59 ± 0.04d | 4.15 ± 0.36c | 0.25 ± 0.05a | 7.67 ± 0.60c | 2.47 ± 0.13a |
Placebo | 0.44 ± 0.06a | 4.84 ± 0.34a | 0.26 ± 0.03a | 6.22 ± 0.64a | 2.41 ± 0.27a | |
6th week | Exp | 0.63 ± 0.04c | 3.87 ± 0.32d | 0.26 ± 0.05a | 8.27 ± 0.53b | 2.47 ± 0.14a |
Placebo | 0.48 ± 0.06a | 4.81 ± 0.36a | 0.26 ± 0.04a | 6.40 ± 0.55a | 2.42 ± 0.25a | |
8th week | Exp | 0.66 ± 0.05b | 3.51 ± 0.44e | 0.29 ± 0.05b | 9.19 ± 0.42a | 2.48 ± 0.13a |
Placebo | 0.48 ± 0.07a | 4.84 ± 0.28a | 0.26 ± 0.03a | 5.89 ± 0.82b | 2.41 ± 0.23a | |
Follow Up (10th week) | Exp | 0.69 ± 0.05a | 3.27 ± 0.34f | 0.29 ± 0.05b | 9.21 ± 0.66a | 2.49 ± 0.11a |
Placebo | 0.49 ± 0.08a | 4.81 ± 0.35a | 0.25 ± 0.04a | 5.93 ± 0.59b | 2.42 ± 0.21a |
Values were expressed as means ± SD. Data within the same column of each group represented by different superscript letters were significantly different (p < 0.05).